Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (117,121)	$ (50,736)
Amounts to reconcile net loss to net cash flows provided by (used in) operating activities:
Provision for deferred income taxes	3,781	26,559
Depreciation and amortization	53,315	53,345
Amortization of deferred financing costs	2,209	1,894
Credit loss on held-to-maturity securities		5,828
Loss from unconsolidated joint ventures	1,609	1,895
Stock-based compensation expense	2,522	2,230
Changes in:
Trade receivables	1,823	(8,345)
Accounts payable and accrued liabilities	(4,785)	(26,297)
Other assets and liabilities	13,760	(1,702)
Net cash flows provided by (used in) operating activities	(42,887)	4,671
Cash Flows from Investing Activities:
Purchases of property and equipment	(25,831)	(43,168)
Investment in other joint ventures	(4,572)	(3,090)
Other investing activities, net	5,462	1,004
Net cash flows used in investing activities	(24,941)	(45,254)
Cash Flows from Financing Activities:
Net borrowings (repayments) under revolving credit facility	(106,000)	400,000
Issuance of senior notes	600,000
Redemption of senior notes	(400,000)
Deferred financing costs paid	(10,540)	(106)
Redemption of noncontrolling interest in Operating Partnership	(2,438)
Payment of dividends	(488)	(50,078)
Payment of tax withholdings for share-based compensation	(3,357)	(1,631)
Other financing activities, net	(58)	(91)
Net cash flows provided by financing activities	75,869	346,844
Net change in cash, cash equivalents, and restricted cash	8,041	306,261
Cash, cash equivalents, and restricted cash, beginning of period	79,754	420,396
Cash, cash equivalents, and restricted cash, end of period	87,795	726,657
Term Loan B
Cash Flows from Financing Activities:
Repayments under term loan B	$ (1,250)	$ (1,250)